• Home
  • Our Company
    • History
    • Ambition
    • Services
    • Group of companies
    • Partners
  • Quality Policy
    • Our Policy
    • Permissions & Certificates
  • Products
    • Portfolio >
      • Epinephrine Base
      • Epinephrine Bitartrate
      • Clenbuterol HCl
      • Scopolamine Base
      • Scopolamine Hydrobromide
      • Scopolamine Methylbromide
      • ... more Products
    • Portfolio TP USA
  • Team
    • Sales & Marketing
    • Logistics
    • Scientific & Regulatory
    • Administration
    • Management
    • TP USA
  • Contact
    • Germany
    • USA
    • Hong Kong
    • Singapore
  • Blog
TRANSOPHARM.COM
  • Home
  • Our Company
    • History
    • Ambition
    • Services
    • Group of companies
    • Partners
  • Quality Policy
    • Our Policy
    • Permissions & Certificates
  • Products
    • Portfolio >
      • Epinephrine Base
      • Epinephrine Bitartrate
      • Clenbuterol HCl
      • Scopolamine Base
      • Scopolamine Hydrobromide
      • Scopolamine Methylbromide
      • ... more Products
    • Portfolio TP USA
  • Team
    • Sales & Marketing
    • Logistics
    • Scientific & Regulatory
    • Administration
    • Management
    • TP USA
  • Contact
    • Germany
    • USA
    • Hong Kong
    • Singapore
  • Blog

Coronavirus Statement

3/18/2020

0 Comments

 
Transo-Pharm continues to closely monitor the widespread impact of the coronavirus disease (COVID-19). The safety and well-being of our employees, customers, partners and suppliers remains our top priority. Additionally, we are committed to supporting our public safety and enterprise customers during this time.
 
A highly skilled team has been put in place and is closely monitoring the situation around the world. We have taken measures to manage the virus’ impact by following guidance from the German Robert Koch Institute, World Health Organization and local governments. These measures include:
  • Remote Work
We have advised employees and contractors to work from home if they can. Those with responsibilities that require them to be on-site to support the mission-critical efforts of our customers have received more information about performing their duties during this time.
  • Restricted Travel
Employees have been instructed to avoid domestic and international travel.
  • Avoiding Large In-Person Meetings and Gatherings
Employees have been asked to avoid attending large in-person meetings and gatherings. Our staff will utilize tele-conferencing tools to stay productive and connected with colleagues, partners and customers.
  • Extra Hygiene Measures
We are implementing additional cleaning procedures at our facilities and continue to share guidance from public health authorities to help prevent the spread of COVID-19.
 
Business Continuity Planning
We are committed to supporting our public safety and enterprise customers during this time, as we do during natural disasters and other widespread emergencies. Business continuity plans we already have in place are being expanded to ensure we can continue to operate and meet the needs of our customers. To provide the best possible service Transo-Pharm has been separated into two groups over the next course of time. We apologize in advance for any inconvenience this may cause. We will do our upmost to continue to provide you with the service you are used to.
 
These enormous efforts on various levels have to be faced as a society.
Transo-Pharm will do its part!
tp-coronavirus_statement.pdf
File Size: 136 kb
File Type: pdf
Download File

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Categories

    All
    Alkaloids
    Cannabinoids
    CBD
    CEP
    Chief Christmas Officers
    COVID 19
    CPhI
    DCAT
    Digoxin
    EDQM
    Epinephrine
    Estriol
    GMP
    Good Bye!
    Hapila
    Little Guy
    Logistics
    Nonivamide
    Partner
    Partnership
    Phyto
    Regulation
    Regulatory
    Safety
    Season Greetings
    Supply Chain
    Transo-Pharm US


    Archives

    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    June 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    June 2020
    May 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019

    RSS Feed

Services

Sourcing
Sales
Development

Products

Portfolio
​US Portfolio

Company

History
Ambition
​Services
Group
Partners
​
Quality Policy 
​Certificates

Team

Sales & Marketing
Logistics
Scientific & Regulatory
Administration
​Management
​TP USA

Contact

Germany
Hong Kong
Singapore
USA
Sitemap
Support
German Site
Imprint / Legal
Data Privacy
Code Of Conduct
© COPYRIGHT 2020
​ALL RIGHTS RESERVED.

Picture
Picture
  • Home
  • Our Company
    • History
    • Ambition
    • Services
    • Group of companies
    • Partners
  • Quality Policy
    • Our Policy
    • Permissions & Certificates
  • Products
    • Portfolio >
      • Epinephrine Base
      • Epinephrine Bitartrate
      • Clenbuterol HCl
      • Scopolamine Base
      • Scopolamine Hydrobromide
      • Scopolamine Methylbromide
      • ... more Products
    • Portfolio TP USA
  • Team
    • Sales & Marketing
    • Logistics
    • Scientific & Regulatory
    • Administration
    • Management
    • TP USA
  • Contact
    • Germany
    • USA
    • Hong Kong
    • Singapore
  • Blog